Abstract: A fluorine-free transparent polymeric material with high oxygen permeability includes at least one silicone cage compound having at least one polymerizable pendant group and up to seven side chains, at least one acrylic compound, at least one acrylate functionalized compound, and styryltris(trimethylsiloxy)silane. None of the compounds of the transparent polymeric material contain the element fluorine. A first polyhedral oligomeric silsesquioxane (POSS) monomer silicone cage has one polymerizable methacrylate pendant group and seven isoalkyl side chains while a second polyhedral oligomeric silsesquioxane (POSS) monomer silicone cage has two polymerizable methacrylate pendant groups and six isoalkyl side chains. The Dk of the transparent polymeric material is approximately 150 and the Shore D hardness is greater than 70.

Abstract: A method of preparing a biocompatible polymeric coating includes preparing an aqueous polymer solution by contacting and reacting methacrylic acid and at least one methacrylate or phosphorylcholine. The methacrylate or phosphorylcholine may include hydroxyethyl methacrylate, polyethylene glycol monomethacrylate, or methacryloyloxyethyl phosphorylcholine. An aqueous coupling agent solution is prepared and is either applied to the substrate surface or is mixed with the polymer solution to form a coating solution. If the coupling agent solution was first applied to the substrate surface, the polymer solution is then applied to the primed substrate surface. Alternatively if a coating solution was created, the coating solution is applied to the substrate surface. In either event, the polymer solution and coupling agent solution react with the substrate to form the biocompatible polymeric coating on the substrate surface.

Abstract: A new class of silicone monomers, providing transparent materials and imparting hydrophilic properties have been developed. These materials are incorporated into ophthalmic devices such as soft and rigid gas permeable (RGP) contact lenses. These new silicone monomers include Polyhedral Oligomeric Silsesquioxane (POSS) with two polymerizable groups and six organofunctional groups. These types of structures incorporate at least two available sites for polymerization allowing for the incorporation of the silsesquioxane cage into the backbone of a macromolecule. Additional functional sites allow the design of specific chemical features which address needed material properties.

Abstract: A method of preparing a biocompatible polymeric coating includes preparing an aqueous polymer solution by contacting and reacting methacrylic acid and at least one methacrylate or phosphorylcholine. The methacrylate or phosphorylcholine may include hydroxyethyl methacrylate, polyethylene glycol monomethacrylate, or methacryloyloxyethyl phosphorylcholine. An aqueous coupling agent solution is prepared and is either applied to the substrate surface or is mixed with the polymer solution to form a coating solution. If the coupling agent solution was first applied to the substrate surface, the polymer solution is then applied to the primed substrate surface. Alternatively if a coating solution was created, the coating solution is applied to the substrate surface. In either event, the polymer solution and coupling agent solution react with the substrate to form the biocompatible polymeric coating on the substrate surface.

Abstract: A method of producing an ultra-high Dk material includes contacting and reacting a fluoroalkyl methacrylate; an alkyl glycol dimethacrylate; a hydrophilic agent, such as methacrylic acid; a hydroxyalkyl tris(trimethylsiloxy)silane; a hydroxyalkyl terminated polydimethylsiloxane; and styrylethyltris(trimethylsiloxy)silane. The reaction is conducted within an inert atmosphere at a pressure of at least 25 pounds per square inch (PSI) and for a period of time and at a temperature sufficient to produce the ultra-high Dk material.

Abstract: A method of producing an ultra-high Dk material includes contacting and reacting a fluoroalkyl methacrylate; an alkyl glycol dimethacrylate; a hydrophilic agent, such as methacrylic acid; a hydroxyalkyl tris(trimethylsiloxy)silane; a hydroxyalkyl terminated polydimethylsiloxane; and styrylethyltris(trimethylsiloxy)silane. The reaction is conducted within an inert atmosphere at a pressure of at least 25 pounds per square inch (PSI) and for a period of time and at a temperature sufficient to produce the ultra-high Dk material.

Abstract: A method of preparing a mixed-phase thermoplastic biomaterial comprises contacting and reacting a diol and a graft pre-polymer comprising a diol and at least one covalently bonded unsaturated monomer with an organic diisocyanate compound. The reaction is conducted within an aprotic solvent and for a period of time and at a temperature sufficient to produce the mixed-phase thermoplastic biomaterial. The diol may be selected from the group consisting of siloxane diols, polyether diols, polyester diols and polycarbonate diols while the at least one covalently bonded unsaturated monomer may be selected from the group consisting of a fluorinated monomer, a siloxane monomer, an aliphatic ester of methacrylic acid, a cyclic ester of methacrylic acid, a charged monomer, a sulfonium salt, a vinyl monomer with phenol or benzoic acid, N-vinyl pyrrolidone, an aminoglucoside, and a therapeutic agent. The mixed-phase thermoplastic biomaterial may further include an anti-microbial, a therapeutic agent or both.

Abstract: A method of preparing a mixed-phase thermoplastic biomaterial comprises contacting and reacting a diol and a graft pre-polymer comprising a diol and at least one covalently bonded unsaturated monomer with an organic diisocyanate compound. The reaction is conducted within an aprotic solvent and for a period of time and at a temperature sufficient to produce the mixed-phase thermoplastic biomaterial. The diol may be selected from the group consisting of siloxane diols, polyether diols, polyester diols and polycarbonate diols while the at least one covalently bonded unsaturated monomer may be selected from the group consisting of a fluorinated monomer, a siloxane monomer, an aliphatic ester of methacrylic acid, a cyclic ester of methacrylic acid, a charged monomer, a sulfonium salt, a vinyl monomer with phenol or benzoic acid, N-vinyl pyrrolidone, an aminoglucoside, and a therapeutic agent. The mixed-phase thermoplastic biomaterial may further include an anti-microbial, a therapeutic agent or both.

Abstract: A method provides a machineable silicon-containing lens blank by removal of diluent from the lens blank. The method involves casting a lens blank in a mold, wherein the lens blank is made of a polymerization product of a monomeric mixture comprising a silicone-containing monomer and an organic diluent; removing the lens blank from the mold; and removing organic diluent from the lens blank.

Abstract: A copolymer useful as a rigid gas permeable contact lens material is the polymerization product of a monomeric mixture comprising a polysiloxane-containing urethane or urea prepolymer endcapped with polymerizable ethylenically unsaturated radicals.

Abstract: Soft, durable, polymeric compositions with one or more reactive polyhedral oligomeric silsesquioxane reinforcing agents and ophthalmic devices such as for example intraocular lenses and corneal inlays made therefrom are described herein.

Abstract: A drug delivery device for placement in the eye includes a drug core comprising a pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes a layer of material permeable to passage of the active agent. The material permeable to passage of the active agent has a degree of crystallinity selected to influence the release kinetics.

Abstract: A copolymer useful as a rigid gas permeable contact lens material is the polymerization product of a monomeric mixture comprising a polysiloxane-containing urethane or urea prepolymer endcapped with polymerizable ethylenically unsaturated radicals.

Abstract: The invention provides, in a first embodiment, a blocking wax composition. The blocking wax comprises from about 50 to about 90 weight percent of a water-soluble continuous phase and from about 10 to about 50 weight percent of a discontinuous solid phase filler that is substantially inert to the continuous phase. The invention further provides a method for mounting a contact lens blank for machining.

Abstract: The present invention is directed toward the renewable surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a removable hydrophilic polymer by means of reaction between reactive functionalities on the hydrophilic polymer which functionalities are complementary to reactive functionalities on or near the surface of the medical device. The present invention is also directed to a contact lens or other medical device having such a surface coating.

Abstract: Soft, durable, polymeric compositions with one or more reactive polyhedral oligomeric silsesquioxane reinforcing agents and ophthalmic devices such as for example intraocular lenses and corneal inlays made therefrom are described herein.

Abstract: The present invention is directed toward the renewable surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a removable hydrophilic polymer by means of reaction between reactive functionalities on the hydrophilic polymer which functionalities are complementary to reactive functionalities on or near the surface of the medical device. The present invention is also directed to a contact lens or other medical device having such a surface coating.

Abstract: The present invention is directed toward the renewable surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a removable hydrophilic polymer by means of reaction between reactive functionalities on the hydrophilic polymer which functionalities are complementary to reactive functionalities on or near the surface of the medical device at reaction temperatures of less than about 55° C.

Abstract: The present invention is directed toward the renewable surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a removable hydrophilic polymer by means of reaction between reactive functionalities on the hydrophilic polymer which functionalities are complementary to reactive functionalities on or near the surface of the medical device. The present invention is also directed to a contact lens or other medical device having such a surface coating.

Abstract: The invention provides, in a first embodiment, a blocking wax composition. The blocking wax comprises from about 50 to about 90 weight percent of a water-soluble continuous phase and from about 10 to about 50 weight percent of a discontinuous solid phase filler that is substantially inert to the continuous phase. The invention further provides a method for mounting a contact lens blank for machining.